Trials / Completed
CompletedNCT00509418
Efficacy and Safety of Viusid in Patients With Nonalcoholic Steatohepatitis
Efficacy and Safety of Viusid, a Nutritional Supplement, in Patients With Nonalcoholic Steatohepatitis. A Randomized, Controlled and Open Label Study
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Catalysis SL · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to evaluate whether Viusid, a nutritional supplement, in combination with diet and exercise improve the histological results (steatosis, necro-inflammatory activity and fibrosis) in comparison with diet and exercise, during 24 weeks of treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Viusid | Viusid, a nutritional supplement. Three oral sachets Daily 24 weeks |
| OTHER | Hypocaloric Diet with controlled exercise | Modified ADA diet in combination with controlled exercise daily 24 weeks |
Timeline
- Start date
- 2007-02-01
- Primary completion
- 2007-09-01
- Completion
- 2007-09-01
- First posted
- 2007-07-31
- Last updated
- 2009-01-12
Locations
1 site across 1 country: Cuba
Source: ClinicalTrials.gov record NCT00509418. Inclusion in this directory is not an endorsement.